Capital Bank & Trust’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-961
Closed -$439K 332
2021
Q1
$439K Buy
961
+152
+19% +$72.5K 0.01% 271
2020
Q4
$377K Sell
809
-370
-31% -$173K ﹤0.01% 277
2020
Q3
$521K Sell
1,179
-211
-15% -$87.2K 0.01% 233
2020
Q2
$504K Sell
1,390
-197
-12% -$66K 0.01% 224
2020
Q1
$450K Buy
1,587
+78
+5% +$24.6K 0.01% 217
2019
Q4
$490K Buy
1,509
+31
+2% +$9.4K 0.01% 231
2019
Q3
$430K Sell
1,478
-849
-36% -$243K 0.01% 229
2019
Q2
$683K Buy
2,327
+439
+23% +$121K 0.01% 207
2019
Q1
$517K Sell
1,888
-301
-14% -$74.9K 0.01% 221
2018
Q4
$490K Buy
2,189
+635
+41% +$149K 0.01% 218
2018
Q3
$379K Buy
1,554
+260
+20% +$59.8K ﹤0.01% 241
2018
Q2
$268K Buy
1,294
+1,000
+340% +$212K ﹤0.01% 259
2018
Q1
$61K Hold
294
﹤0.01% 368
2017
Q4
$56K Buy
294
+38
+15% +$7.28K ﹤0.01% 409
2017
Q3
$48K Hold
256
﹤0.01% 382
2017
Q2
$45K Buy
+256
New +$43K ﹤0.01% 362

Other funds holding TMO

Capital Bank & Trust's TMO Position: Q2 2021 in Review

Capital Bank & Trust sold out of Thermo Fisher Scientific (TMO) in Q2 2021, closing a stake of 961 shares — an estimated $439K sold.

Capital Bank & Trust first reported a position in TMO in Q2 2017 and held it in 16 quarters. The position peaked at $683K in Q2 2019. 2,074 funds tracked by Wall St. Rank hold TMO as of Q2 2021.

  • Capital Bank & Trust reported no remaining Thermo Fisher Scientific position as of Q2 2021 after selling out during the quarter.
  • Capital Bank & Trust sold 961 Thermo Fisher Scientific shares in Q2 2021, an estimated $439K.
  • Capital Bank & Trust first reported a position in Thermo Fisher Scientific in Q2 2017 and held it in 16 quarters.
  • Capital Bank & Trust's Thermo Fisher Scientific position peaked at $683K in Q2 2019.
  • 2,074 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2021.

Based on Capital Bank & Trust's 13F filing for Q2 2021, filed 16 Aug 2021.